GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » ROE % Adjusted to Book Value

Starton Therapeutics (Starton Therapeutics) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics ROE % Adjusted to Book Value?

Starton Therapeutics's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Starton Therapeutics's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Starton Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.


Starton Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Starton Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics ROE % Adjusted to Book Value Chart

Starton Therapeutics Annual Data
Trend Mar21 Mar22 Mar23
ROE % Adjusted to Book Value
- - -

Starton Therapeutics Quarterly Data
Mar21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Starton Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Starton Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starton Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's ROE % Adjusted to Book Value falls into.



Starton Therapeutics ROE % Adjusted to Book Value Calculation

Starton Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Starton Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starton Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Starton Therapeutics (Starton Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
215 College Road, Suite No.300, Paramus, NJ, USA, 07652
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines